Navigation Links
Tosoh Bioscience Introduces TSK-GEL SP-3PW (30), a Higher-Capacity Resin for the Purification of Insulin and Other Therapeutic Peptides and Small Proteins
Date:5/25/2010

Contains a smaller pore for improved resolution combined with unique selectivity and higher capacity than TSK-GEL SP-5PW resin for purification of insulin and other peptides and small proteins.

King of Prussia, PA (PRWEB) May 25, 2010 -- Tosoh Bioscience LLC, a provider of chromatographic solutions for biopurification, recently announced the introduction of a new line of TSK-GEL SP-3PW (30) resins for use in large scale purification of peptides and proteins. Packaging container volumes vary from 100mL up to 50L.

The TSK-GEL SP-3PW (30) resin is manufactured with a new production technology which yields a narrower particle size distribution. The 250Å pore of the particles is ideal for insulin and similarly sized molecules. The smaller pore size coupled with a higher ligand density account for the higher capacity over TSK-GEL 5PW resins.

The new polymer technology creates an additional selectivity tool for use by the developer for demanding separation problems. TSK-GEL SP-3PW (30) resins can be used for both polishing and intermediate purification process steps.

According to Al Jackewitz, marketing manager of process development resins at Tosoh Bioscience LLC, the new resin can be made in larger batches than the other TSK-GEL SP-5PW resins, and the new technology may be applied to other ligands in the near future.

The new resin is in inventory and now available for purchase.

TOSOH BIOSCIENCE LLC

Tosoh Bioscience LLC provides liquid chromatography products to laboratories and manufacturing plants in the Americas. While the majority of our customers are employed in biotechnology and pharmaceutical companies, our HPLC columns and systems are essential tools for sample analysis in most industries. Our dedicated size-exclusion HPLC system is predominantly used in the chemical and electronic industries. In the field of biotechnology, our preparative chromatography resins play a critical role in the purification of proteins and nucleic acids for medical purposes.

The company is a subsidiary of Tosoh Corporation in Japan, the parent of the Tosoh Group, which comprises 141 companies worldwide and a multiethnic workforce of over 10,000 people and generates sales of ¥827 billion (US$8.3 billion) annually.

For more information, please contact
Al Jackewitz
Biopurification Market Manager
Tosoh Bioscience LLC
484-805-1219

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4043554.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic Applications of ZFP Technology
2. YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting
3. YM BioSciences third quarter 2010 operational and financial results
4. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
5. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
6. YM BioSciences announces controlled equity offering
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
8. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
9. Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
10. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
11. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tosoh Bioscience Introduces TSK-GEL SP-3PW (30), a Higher-Capacity Resin for the Purification of Insulin and Other Therapeutic Peptides and Small Proteins 
(Date:2/4/2016)... EDISON, N.J. , Feb. 4, 2016 ... company focused on the development and commercialization of targeted ... BIO CEO & Investor Conference 2016, to be held ... and Source Capital Group,s 2016 Disruptive Growth & Healthcare ... on February 10-11, 2016. James Sapirstein ...
(Date:2/4/2016)... , February 4, 2016 ... Laboratories (ABL), Inc. --> Strasbourg, France ... --> PharmaVentures is pleased to announce that it ... its biopharmaceutical manufacturing unit in Strasbourg, France ... --> --> Transgene (Euronext: ...
(Date:2/3/2016)... -- With the growing need for better therapeutics, and ... such as monoclonal antibodies, recombinant protein therapeutics and ... are in high demand. Conventionally expression systems were ... of these therapeutics. However, due to issues with ... approaches and novel expression systems are currently being ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... a new office dedicated to the North American healthcare market. , Aerocom Healthcare, ... healthcare facilities. The company will provide new pneumatic tube systems or expand ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
Breaking Biology News(10 mins):